Edition:
United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

5.10CNY
15 Dec 2017
Change (% chg)

¥-0.01 (-0.20%)
Prev Close
¥5.11
Open
¥5.11
Day's High
¥5.11
Day's Low
¥5.07
Volume
1,420,577
Avg. Vol
4,218,234
52-wk High
¥7.60
52-wk Low
¥4.96

Latest Key Developments (Source: Significant Developments)

North China Pharmaceutical issues 2017 second tranche corporate bonds worth 290 mln yuan
Wednesday, 27 Sep 2017 09:22pm EDT 

Sept 28(Reuters) - North China Pharmaceutical Co Ltd <600812.SS>:Says it issued 2017 second tranche corporate bonds worth 290 million yuan.  Full Article

North China Pharmaceutical issues 2017 2nd series super short-term debentures worth 500 mln yuan
Thursday, 3 Aug 2017 05:05am EDT 

Aug 3 (Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says it issues 2017 the second series super short-term debentures worth 500 million yuan, with coupon rate of 5.08 percent and maturity date on Jan. 29, 2018.  Full Article

North China Pharmaceutical issues 210 mln yuan worth of corporate bonds
Wednesday, 2 Aug 2017 09:26am EDT 

Aug 2 (Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says it issues 210 mln yuan worth of 2017 public offering corporate bonds .  Full Article

North China Pharmaceutical sets coupon rate for 2017 corporate bonds at 6.5 pct
Monday, 31 Jul 2017 05:32am EDT 

July 31(Reuters) - North China Pharmaceutical Co Ltd <600812.SS>:Says it sets coupon rate for 2017 corporate bonds at 6.5 percent .Previous news was disclosed on July 25.  Full Article

North China Pharmaceutical's unit receives GMP certificate
Monday, 17 Jul 2017 11:27pm EDT 

July 18 (Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says co's pharmacy unit received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration, for its sterile APIs (amoxicillin/sulbactam), with the valid period is until June 22, 2022.  Full Article

North China Pharmaceutical unit receives GMP certificate
Wednesday, 12 Jul 2017 01:47am EDT 

July 12 (Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says co's unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration for its powder injection production line .  Full Article

North China Pharmaceutical issues 2017 1st tranche super short-term financing notes worth 1 bln yuan
Monday, 10 Jul 2017 03:03am EDT 

July 10(Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says it issued 2017 1st tranche super short-term financing notes worth 1 billion yuan with a term of 270 days and interest rate of 5.3 percent.  Full Article

North China Pharmaceutical receives GMP certificate
Wednesday, 21 Jun 2017 04:25am EDT 

June 21(Reuters) - North China Pharmaceutical Co Ltd <600812.SS> ::* Says it received goods manufacture practice (GMP) certificate from Shijiazhuang Food and Drug Administration.* Says certificate issued to soft capsules, oral solution, granules, manufactured by the company and the valid period is until May 26, 2022.  Full Article

North China Pharmaceutical unit gets Certificate of Suitability to Monograph of European Pharmacopoeia
Sunday, 16 Apr 2017 10:35pm EDT 

April 17(Reuters) - North China Pharmaceutical Co Ltd <600812.SS>:Says wholly owned unit received Certificate of Suitability to Monograph of European Pharmacopoeia, from European Directorate for Quality of Medicines & HealthCare, for AMOXICILLIN TRIHYDRATE.Certificate valid for 5 years.  Full Article

North China Pharmaceutical receives GMP certificate
Wednesday, 22 Mar 2017 05:41am EDT 

North China Pharmaceutical Co Ltd <600812.SS> : Says it received goods manufacture practice(GMP) certificate from Hebei Food and Drug Administration on March 21 . Certificate issued to production line for manufacturing Amoxicillin Dispersible tablets, Amoxicillin and Clavulanate Potassium tablets and Amoxil capsule .Valid until Feb. 23, 2022.  Full Article